This paper is in the following e-collection/theme issue:

Methods and Feasibility Studies (380) Cancer and Clinical Trials (19)

Published on in Vol 6, No 3 (2017): March

Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility

Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility

Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility

Authors of this article:

Bin Li1 Author Orcid Image ;   Steven A Eschrich2 Author Orcid Image ;   Anders Berglund2 Author Orcid Image ;   Melissa Mitchell3 Author Orcid Image ;   David Fenstermacher4 Author Orcid Image ;   Hadi Danaee5 Author Orcid Image ;   Hongyue Dai6 Author Orcid Image ;   Daniel Sullivan7 Author Orcid Image ;   William L Trepicchio5 Author Orcid Image ;   William S Dalton3 Author Orcid Image
Article Authors Cited by (6) Tweetations (2) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.